Agissez maintenant: soutenez la déclaration de la société civile : « Projet zéro »
On 28 April 2011, the official Zero Draft UN Declaration was released. The document will be used as the basis of negotiations for the declaration intended as an outcome of the High-level Meeting on HIV/AIDS in New York, 8-10 June 2011.
Zero Draft Civil Society Declaration
Over the last few months consultations by national, regional and global AIDS advocates and representatives of key populations’ networks have led to many sets of civil society ‘asks’ of governments to respond to HIV and AIDS. It was crucial to urgently develop a coordinated civil society approach to the negotiations for the outcome declaration from the UN General Assembly Comprehensive AIDS review High Level Meeting (HLM) in June 2011.
Out of these many consultations a “zero draft” civil society declaration has been developed by national, regional, global and constituency-based organizations to assist in coordinated civil society advocacy with UN member states (governments). The "zero draft” will immediately be used for negotiations with governments in New York and in the national capitals around the world as consultations with member states has already begun.
Actions you can take
Sign-up your organization to this “zero draft” civil society declaration by sending an email to universalaccess2010@icaso.org.
Use the “zero draft” immediately to negotiate and advocate with government representatives in your home capitals and with government missions to the UN in New York.
Share your feedback/intelligence from meetings with governments with your civil society colleagues. You can join the civil society email group ‘aidsreview2011’ by sending an email to universalaccess2010@icaso.org with “join aidsreview2011’ in the subject line.
Updated versions of the civil society draft declaration will be shared to reflect advances in the negotiations of the UN “zero draft”. The full list of endorsements will be sent to all UN Missions in New York and other key stakeholders.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.